What adverse effects can result from drinking green tea?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 17, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Adverse Effects of Green Tea Consumption

Drinking green tea is generally safe at moderate consumption levels (1-3 cups daily), but concentrated green tea extracts can cause hepatotoxicity, particularly when consumed in large bolus doses on an empty stomach, and may significantly reduce the absorption and efficacy of multiple medications.

Primary Safety Concerns

Hepatotoxicity (Liver Damage)

The most serious adverse effect is liver injury from concentrated green tea extracts, particularly those high in catechins and EGCG (epigallocatechin gallate). 1 established a safe intake level of 338 mg EGCG/day for adults when consumed as solid bolus doses, with an Observed Safe Level of 704 mg EGCG/day for tea in beverage form.

Key risk factors for liver toxicity include:

  • Consuming concentrated extracts (not brewed tea) 1
  • Taking supplements on an empty stomach 2
  • Large bolus dosing rather than gradual consumption throughout the day 1
  • Use in weight-loss supplements 3, 4

Case reports document severe outcomes including acute liver failure in adolescents using green tea extract supplements 4, and combined acute pancreatitis with toxic hepatitis after consuming only green tea catechin supplements for 2 weeks 3.

Caffeine-Related Effects

Green tea contributes approximately 17% of total caffeine intake in the US population 5. Adverse caffeine effects occur at intakes >400 mg/day in adults and include:

  • Agitation and anxiety
  • Sleep disturbance
  • Behavioral issues (particularly in children at >2.5 mg/kg body weight/day) 5

Special populations requiring caffeine restriction:

  • Pregnant women: limit to 200 mg/day (European Food Safety Authority) or 300 mg/day (other guidelines) 5
  • Children and adolescents: <2.5 mg/kg body weight/day 5

Drug Interactions

Green tea catechins significantly alter drug pharmacokinetics in 72% of studied medications 6. The most clinically important interactions involve:

Drugs with decreased absorption (18-99% reduction in systemic exposure):

  • Cardiovascular medications: atorvastatin, celiprolol, nadolol, rosuvastatin, lisinopril
  • Fexofenadine (antihistamine)
  • Raloxifene (osteoporosis)
  • Nintedanib (pulmonary fibrosis)
  • Digoxin (heart failure)
  • Folic acid 6

The mechanism involves inhibition of OATP1A2 intestinal uptake transporters, enhanced P-glycoprotein efflux, and reduced drug solubility 6. These interactions can compromise drug efficacy (e.g., reduced blood pressure control with nadolol) or safety.

Gastrointestinal Effects

Recent Mendelian randomization analysis suggests potential causal associations:

  • Protective effects: Reduced risk of esophagitis and gastric cancer 7
  • Adverse effects: Increased risk of Crohn's disease, cholangitis 7
  • Mixed evidence for gastroesophageal reflux and diverticulosis 7

Clinical Recommendations Based on Guidelines

For healthy adults 5:

  • Brewed green tea at 1-3 cups/day (237-710 mL) is associated with cardiovascular benefits and reduced mortality
  • Limit total caffeine to ≤400 mg/day
  • Avoid concentrated green tea extract supplements, especially on an empty stomach

For pregnant women 5:

  • Limit caffeine to ≤200 mg/day (European standard) or ≤300 mg/day
  • This equates to approximately 1-2 cups of tea daily

For children and adolescents 5:

  • Caffeine intake <2.5 mg/kg body weight/day
  • Equivalent to 1-2 cups of tea or 1 small cup of coffee daily
  • Avoid caffeinated soft drinks due to acidity, higher caffeine content, and added sugars

For patients on medications 6:

  • Separate green tea consumption from medication dosing by at least 4 hours for drugs metabolized by OATP1A2 or P-glycoprotein
  • Monitor therapeutic efficacy closely for cardiovascular drugs, particularly statins, beta-blockers, and digoxin
  • Consider therapeutic drug monitoring when clinically indicated

Critical Pitfalls to Avoid

  1. Do not assume "natural" equals safe: Concentrated extracts in supplements are fundamentally different from brewed tea 1, 8

  2. Fasting amplifies toxicity: Animal studies show lethal toxicity in fasted but not fed states at identical doses 2

  3. Weight-loss supplements are highest risk: Multiple case reports link severe hepatotoxicity to green tea extract weight-loss products 3, 4

  4. Drug interactions are dose-dependent: Even moderate green tea consumption can significantly reduce drug absorption for susceptible medications 6

  5. Symptoms may be delayed: Hepatotoxicity can develop after weeks of supplement use 3

The evidence strongly supports that brewed green tea in moderation (1-3 cups daily) is safe and beneficial, while concentrated extracts, particularly in supplement form, carry significant hepatotoxic risk 1. The key distinction is between traditional tea consumption and highly concentrated catechin supplements marketed for weight loss or other health claims.

Related Questions

Is daily consumption of four to five cups of organic tea safe for a healthy adult?
A 10‑day postpartum woman presents with dysuria and a urine culture growing mixed microbiota >100,000 CFU/mL; how should this be managed?
What is the appropriate 10‑day antibiotic regimen for a patient undergoing ENT follow‑up after image‑guided fine‑needle aspiration/biopsy, assuming no documented β‑lactam allergy?
In a 10‑month‑old infant with a slightly indented coronal suture, normal fontanelles, and appropriate head growth, what is the appropriate next step in management?
What is the minimum recommended duration of antimicrobial therapy for a deep puncture wound?
Can a sodium-glucose cotransporter-2 (SGLT2) inhibitor be started in a diabetic patient with pyuria and possible vulvar candidiasis who is afebrile?
In a patient with persistent irritable bowel syndrome symptoms and frequent food intolerances who shows low‑grade inflammation on colonoscopy, how should this finding be evaluated and managed?
What investigations are indicated for a 25-year-old patient with isolated central retinal vein occlusion?
In a patient with chronic kidney disease and fluid overload, should the IV fluid be plain lactated Ringer’s solution or plain normal saline (0.9% NaCl)?
What is the appropriate cefdinir dosing for an uncomplicated urinary tract infection in adults, children, and patients with renal impairment?
What is the most likely diagnosis, appropriate investigations, treatment, and two critical complications to monitor in a 25-year-old primiparous woman 7 days after an uncomplicated caesarean section who presents with severe progressive headache, occasional visual blurring, nausea, lethargy, blood pressure of 130/80 mm Hg, and bilateral papilledema?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.